Scholarlink

<p>Tumor-infiltrating neutrophils (TINs) are highly heterogeneous and mostly immunosuppressive in the tumor immune microenvironment (TIME). Current biomarkers of TINs and treatment strategies targeting TINs have not yielded optimal responses in patients across cancer types. Here, we separated human and mouse neutrophils into three developmental stages, including promyelocyte (PM), myelocyte &amp; metamyelocyte (MC &amp; MM), and band &amp; segmented (BD &amp; SC) neutrophils. Based on this separation, we observed the predominance of human but not mouse MC &amp; MM-stage neutrophils in bone marrow (BM), which exhibit potent immunosuppressive and tumor-promoting properties. MCs &amp; MMs also occupy the majority of TINs among patients with 17 cancer types. Moreover, through the creation of a NOD/ShiLtJGpt-Prkdc<sup>em26Cd52</sup>Il2rg<sup>em26Cd22</sup>/Gpt (NCG)-<i>Gfi1</i><sup>−/−</sup> human immune system (HIS) mouse model, which supports efficient reconstitution of human TIN, we found a significant increase of BM MCs &amp; MMs in tumor-bearing mice. By comparing the single-cell RNA sequencing analysis results of human neutrophils from both BM and tumors, we found that CD63 and Galectin-3 distinguish MC &amp; MM from neutrophil populations in cancer patients. Furthermore, we proposed a strategy with Fms-like tyrosine kinase 3 ligand to specifically induce the trans-differentiation of MCs &amp; MMs into monocytic cells, and trigger tumor control in NCG-<i>Gfi1</i><sup>−/−</sup> HIS mice. Thus, our findings establish an essential role of human MC &amp; MM-stage neutrophils in promoting cancer progression, and suggest their potential as targets for developing potential biomarkers and immunotherapies for cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Human myelocyte and metamyelocyte-stage neutrophils suppress tumor immunity and promote cancer progression

  • 期刊论文

  • 发表日期：

    2025年7月15日

查看全文
  • Wei Liu,
  • Tao Shi,
  • Chun Lu,
  • Keying Che,
  • Zijian Zhang,
  • Yuting Luo,
  • Daniel Hirschhorn,
  • Hanbing Wang,
  • Shaorui Liu,
  • Yan Wang,
  • Shuang Liu,
  • Haiqiao Sun,
  • Jun Lu,
  • Yuan Liu,
  • Dongquan Shi,
  • Shuai Ding,
  • Heping Xu,
  • Liaoxun Lu,
  • Jianming Xu,
  • Jun Xin,
  • Yinming Liang,
  • Taha Merghoub,
  • Jia Wei,
  • Yan Li

摘要

Tumor-infiltrating neutrophils (TINs) are highly heterogeneous and mostly immunosuppressive in the tumor immune microenvironment (TIME). Current biomarkers of TINs and treatment strategies targeting TINs have not yielded optimal responses in patients across cancer types. Here, we separated human and mouse neutrophils into three developmental stages, including promyelocyte (PM), myelocyte & metamyelocyte (MC & MM), and band & segmented (BD & SC) neutrophils. Based on this separation, we observed the predominance of human but not mouse MC & MM-stage neutrophils in bone marrow (BM), which exhibit potent immunosuppressive and tumor-promoting properties. MCs & MMs also occupy the majority of TINs among patients with 17 cancer types. Moreover, through the creation of a NOD/ShiLtJGpt-Prkdcem26Cd52Il2rgem26Cd22/Gpt (NCG)-Gfi1−/− human immune system (HIS) mouse model, which supports efficient reconstitution of human TIN, we found a significant increase of BM MCs & MMs in tumor-bearing mice. By comparing the single-cell RNA sequencing analysis results of human neutrophils from both BM and tumors, we found that CD63 and Galectin-3 distinguish MC & MM from neutrophil populations in cancer patients. Furthermore, we proposed a strategy with Fms-like tyrosine kinase 3 ligand to specifically induce the trans-differentiation of MCs & MMs into monocytic cells, and trigger tumor control in NCG-Gfi1−/− HIS mice. Thus, our findings establish an essential role of human MC & MM-stage neutrophils in promoting cancer progression, and suggest their potential as targets for developing potential biomarkers and immunotherapies for cancer.